EN\CN

About Us

Stemirna Therapeutics Co., ltd. is a high-tech biotechnology company found by a group of returning PhDs of MD Anderson Cancer Center based in Zhangjiang Free Trade Zone, Pudong, Shanghai.....

R&D Platform

以斯微生物RNA类药物研发的创新技术为主要研发手段,依托上海东方医院、郑州大学第一附属医院等大型医院丰富的患者资源,结合基因检测、靶向给药等精准医学手段,以研发出治疗恶性肿瘤、重大感染性疾病、罕见疾病为有效RNA类药物为主要目标。

mRNA drug platform

establish drug development foundation platform, create mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases and genetic diseases, participate in domestic and international market competition, promote the development of mRNA drugs.

mRNA GMP production center

establish the first mRNA GMP production center to produce mRNA drugs and related preparations, strictly follow GMP requirements to produce high quality products for scientific research and clinical services.

Tumor neoantigen library

establish the first personalized tumor neoantigen library, provide accurate target for the new generation of mRNA personalized cancer vaccines.

mRNA drug clinical cooperation platform

supported by strong medical and clinical background, establish and improve the project evaluation, clinical studies, clinical trials, data analysis and clinical transformation team, continuously promoting the transformation of mRNA drug development and clinical treatment, promote the development of clinical application and industry of mRNA drugs.

Advantage

  • 专注RNA类药物技术研发

    利用先进科技,研发mRNA类和microRNA类药物。

  • 专业高效的转化平台

    联合海内外的临床和生物治疗专家,打造专业高效的新药转化平台

  • RNA类药物合成及生产基地

    根据FDA和EMA的标准打造高标准的RNA类药物生产基地,提供委托生产服务

  • 丰富的专家资源

    根据FDA和EMA的标准打造高标准的RNA类药物生产基地,提供委托生产服务